Patient Navigation for Colorectal Cancer Screening (SCREEN)

October 20, 2025 updated by: Medstar Health Research Institute

Bridging the Gap: Delivering Equitable Colorectal Cancer Screening

Patient navigation is an evidence-based strategy to increase screening rates among racial and ethnic minorities, but there is a gap in understanding the multi-level influences on implementation of such programs across primary care practices. The investigators will conduct a stepped-wedge, randomized trial to roll out patient navigation and patient and provider reminders across 15 clinics (3 clinics per step, 5 six-month steps). Implementation strategies will include assessing for readiness, audit and feedback, building a community coalition, engaging consumers, modifying referral tracking, and training and educating clinical stakeholders. The research team will use the electronic health record data with consideration for the Observational Medical Outcomes Partnership (OMOP) Common Data Model, additional patient-reported data, and study tracking logs to measure reach, effectiveness, adoption, implementation, and will use qualitative measures and site observations to document contextual factors, including examination of discrimination in patient experiences and provider referral patterns that may influence intervention delivery or colorectal cancer screening completion.

Study Overview

Status

Enrolling by invitation

Detailed Description

Colorectal cancer (CRC) screening is recommended by the United States Preventative Services Task Force for adults age 45-75. Patient navigation is an evidence-based strategy to increase screening rates among racial and ethnic minorities. While patient navigation is an evidence-based approach to improve screening, there is a gap in understanding the multi-level influences on implementation of such programs across primary care practices, particularly using a health-equity focused, stakeholder-centered approach. Guided by the Practical, Robust Implementation and Sustainability Model (PRISM) and core health and racial equity principles, the investigative team aims to increase reach of patient navigation and show effectiveness through improvement in the percentage of Black and Hispanic patients completing CRC screening. Investigators will also utilize longitudinal tracking of implementation strategies to better track implementation or intervention adaptations navigation delivery in order to inform future scale up. The research team will conduct a stepped-wedged, randomized trial to roll out patient navigation and patient and provider reminders across 15 clinics (3 clinics per step, 5 six-month steps). Implementation strategies will include assessing for readiness, audit and feedback, building a community coalition, engaging consumers, modifying referral tracking, and training and educating clinical stakeholders. Researchers will use the electronic health record data with consideration for the Observational Medical Outcomes Partnership (OMOP) Common Data Model, additional patient-reported data, and study tracking logs to measure reach, effectiveness, adoption, implementation, and will use qualitative measures and site observations to document contextual factors, including examination of discrimination in patient experiences and provider referral patterns that may influence intervention delivery or CRC screening completion.

Study Type

Interventional

Enrollment (Estimated)

1800

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • District of Columbia
      • Washington D.C., District of Columbia, United States, 20007
        • Internal Medicine Wisconsin Avenue
      • Washington D.C., District of Columbia, United States, 20016
        • Family Medicine Spring Valley
      • Washington D.C., District of Columbia, United States, 20036
        • Primary Care Lafayette
      • Washington D.C., District of Columbia, United States, 20722
        • Family Medicine Fort Lincoln
    • Maryland
      • Baltimore, Maryland, United States, 21128
        • Honeygo
      • Baltimore, Maryland, United States, 21218
        • MedStar Adult Medicine at Union Memorial
      • Baltimore, Maryland, United States, 21230
        • Harbor Hospital Primary Care Federal Hill
      • Baltimore, Maryland, United States, 21237
        • Franklin Square
      • Baltimore, Maryland, United States, 21237
        • Primary Care at Franklin Square
      • Charlotte Hall, Maryland, United States, 20622
        • Charlotte Hall
      • Clinton, Maryland, United States, 20735
        • Internal Medicine Clinton
      • Gaithersburg, Maryland, United States, 20878
        • Family Medicine
      • Hyattsville, Maryland, United States, 20782
        • Internal Medicine Hyattsville
      • Olney, Maryland, United States, 20832
        • Family Medicine
      • Olney, Maryland, United States, 20832
        • Olney Prof Park

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 45-75
  • Due for colorectal cancer screening
  • Identify as Black or Hispanic/Latino
  • Attend primary care visit at one of the 15 selected clinics within the step time -period

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care
Experimental: Patient navigation
Patient navigation will be rolled out at the clinic level (15 clinics). Referral orders will become available to participating clinics, with education and audit and feedback for providers. The study team will tailor patient navigation supports by clinic site for specifics on how the intervention is delivered.
Clinics will receive educational materials and access a referral order for patient navigation. Iterative strategies will be used to increase CRC screening

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Colorectal cancer screening completion
Time Frame: 12 months
Completion of any USPSTF approved screening test
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reach
Time Frame: 6 months
Percent of patients referred out of those eligible
6 months
Adoption
Time Frame: 6 months
Percent of providers referring to patient navigation
6 months
Acceptability measured by the Acceptability of Intervention Measure (AIM)
Time Frame: 12 months
Stakeholder assessments of acceptability of navigation and implementation strategies measured on a four-item scale
12 months
Appropriateness measured by the Intervention Appropriateness Measure (IAM)
Time Frame: 12 months
Stakeholder assessments of appropriateness of navigation and implementation strategies measured on a four-item scale
12 months
Feasibility measured by the Feasibility of Implementation Measure (FIM)
Time Frame: 12 months
Stakeholder assessments of feasibility of navigation and implementation strategies measured on 4 item scale
12 months
Sustainability measured by the clinical sustainability assessment tool
Time Frame: 12 months
Understanding clinical sustainability of interventions
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2024

Primary Completion (Estimated)

January 30, 2028

Study Completion (Estimated)

July 30, 2028

Study Registration Dates

First Submitted

April 22, 2024

First Submitted That Met QC Criteria

May 2, 2024

First Posted (Actual)

May 6, 2024

Study Record Updates

Last Update Posted (Estimated)

October 22, 2025

Last Update Submitted That Met QC Criteria

October 20, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Cancer Screening

Clinical Trials on Delivery of patient navigation

Subscribe